Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed director
Auditor change
Quarterly results
Credit agrmnt [a]
|
|
Apollo Endosurgery, Inc. (APEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/08/2023 |
SC 13G/A
| CITIGROUP INC reports a 0% stake in Apollo Endosurgery, Inc. |
| 04/14/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
| 04/04/2023 |
4
| McGaughy R Kent Jr (10% Owner) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 675,181 shares
@ $0
Disposed/sold 1,310,701 shares
@ $0
Disposed/sold 3,687,781 shares
@ $0
Disposed/sold 45,594 shares
@ $0
Disposed/sold 63,671 shares
@ $0
Disposed/sold 400,675 shares
@ $0
Disposed/sold 38,667 options to buy
@ $3.95, valued at
$152.7k
|
|
| 04/04/2023 |
4
| CPMG Inc (10% Owner) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 675,181 shares
@ $0
Disposed/sold 1,310,701 shares
@ $0
Disposed/sold 3,687,781 shares
@ $0
Disposed/sold 45,594 shares
@ $0
Disposed/sold 63,671 shares
@ $0
Disposed/sold 400,675 shares
@ $0 |
|
| 04/04/2023 |
4
| BARR JOHN R (Director) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 44,082 shares
@ $0
Disposed/sold 5,271 options to buy
@ $8.86, valued at
$46.7k
Disposed/sold 16,536 options to buy
@ $3.27, valued at
$54.1k
Disposed/sold 29,317 options to buy
@ $2.08, valued at
$61k
Disposed/sold 19,333 options to buy
@ $3.95, valued at
$76.4k
|
|
| 04/04/2023 |
4
| Bankes Jeannette (Director) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 17,641 shares
@ $0
Disposed/sold 9,533 options to buy
@ $5.3, valued at
$50.5k
Disposed/sold 19,333 options to buy
@ $3.95, valued at
$76.4k
|
|
| 04/04/2023 |
4
| O'KEEFE SHARON (Director) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 35,604 shares
@ $0 |
|
| 04/04/2023 |
4
| McKhann Chas (President and CEO) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 689,880 shares
@ $0
Disposed/sold 848,733 options to buy
@ $5.95, valued at
$5M
Disposed/sold 459,170 options to buy
@ $3.95, valued at
$1.8M
|
|
| 04/04/2023 |
4
| McClellan William D. Jr. (Director) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 39,249 shares
@ $0
Disposed/sold 2,000 shares
@ $0
Disposed/sold 1,437 options to buy
@ $3.36, valued at
$4.8k
Disposed/sold 4,844 options to buy
@ $6.5, valued at
$31.5k
Disposed/sold 9,848 options to buy
@ $6.58, valued at
$64.8k
Disposed/sold 16,536 options to buy
@ $3.27, valued at
$54.1k
Disposed/sold 28,446 options to buy
@ $2.08, valued at
$59.2k
Disposed/sold 5,271 options to buy
@ $8.86, valued at
$46.7k
Disposed/sold 19,333 options to buy
@ $3.95, valued at
$76.4k
|
|
| 04/04/2023 |
4
| Molesphini John J (EVP, Operations) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 92,626 shares
@ $0
Disposed/sold 49,500 options to buy
@ $7.75, valued at
$383.6k
Disposed/sold 30,973 options to buy
@ $3.49, valued at
$108.1k
Disposed/sold 61,949 options to buy
@ $2.08, valued at
$128.9k
Disposed/sold 16,627 options to buy
@ $5.95, valued at
$98.9k
Disposed/sold 26,539 options to buy
@ $5.63, valued at
$149.4k
|
|
| 04/04/2023 |
4
| Gostout Christopher J. (Chief Medical Officer) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 90,267 shares
@ $0
Disposed/sold 3,450 options to buy
@ $2.09, valued at
$7.2k
Disposed/sold 135,000 options to buy
@ $0
Disposed/sold 14,050 options to buy
@ $6.58, valued at
$92.4k
Disposed/sold 25,442 options to buy
@ $3.49, valued at
$88.8k
Disposed/sold 51,610 options to buy
@ $2.08, valued at
$107.3k
Disposed/sold 11,876 options to buy
@ $5.95, valued at
$70.7k
Disposed/sold 6,635 options to buy
@ $5.63, valued at
$37.4k
|
|
| 04/04/2023 |
4
| Gutteridge Mike (VP, Int'l Sales and Marketing) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 86,647 shares
@ $0
Disposed/sold 14,000 options to buy
@ $6.5, valued at
$91k
Disposed/sold 25,500 options to buy
@ $4.37, valued at
$111.4k
Disposed/sold 22,655 options to buy
@ $3.49, valued at
$79.1k
Disposed/sold 22,171 options to buy
@ $2.08, valued at
$46.1k
Disposed/sold 14,846 options to buy
@ $5.95, valued at
$88.3k
Disposed/sold 11,611 options to buy
@ $5.63, valued at
$65.4k
|
|
| 04/04/2023 |
4
| Black Jeffrey G. (CFO) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 335,330 shares
@ $0
Disposed/sold 150,000 options to buy
@ $8.69, valued at
$1.3M
Disposed/sold 120,834 options to buy
@ $3.95, valued at
$477.3k
|
|
| 04/04/2023 |
4
| Shimer Julie Ann (Director) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 36,021 shares
@ $0
Disposed/sold 8,002 options to buy
@ $7.75, valued at
$62k
Disposed/sold 16,536 options to buy
@ $3.27, valued at
$54.1k
Disposed/sold 28,156 options to buy
@ $2.08, valued at
$58.6k
Disposed/sold 5,271 options to buy
@ $8.86, valued at
$46.7k
Disposed/sold 19,333 options to buy
@ $3.95, valued at
$76.4k
|
|
| 04/04/2023 |
4
| Pacitti David (Director) has filed a Form 4 on Apollo Endosurgery, Inc.|
Txns:
| Disposed/sold 18,112 shares
@ $0
Disposed/sold 15,154 options to buy
@ $3.98, valued at
$60.3k
Disposed/sold 16,536 options to buy
@ $3.27, valued at
$54.1k
Disposed/sold 27,749 options to buy
@ $2.08, valued at
$57.7k
Disposed/sold 5,271 options to buy
@ $8.86, valued at
$46.7k
Disposed/sold 19,333 options to buy
@ $3.95, valued at
$76.4k
|
|
| 04/04/2023 |
SC 13G
| HEDGEHOG CAPITAL LLC reports a 5.6% stake in Apollo Endosurgery, Inc. |
| 04/04/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/04/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/04/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/04/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/04/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/04/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/04/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/04/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/04/2023 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
| 04/04/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/04/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/04/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/04/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/04/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/04/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/04/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/04/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 04/04/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
|
|
|